Dow Up 0.76% Nasdaq Up 0.69%

Celsion Corp. (CLSN)

-NasdaqCM
2.59 Up 0.05(1.97%) Oct 24, 3:59PM EDT
Prev Close:2.54
Open:2.53
Bid:2.40 x 100
Ask:2.59 x 1300
1y Target Est:8.00
Beta:1.85
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:2.46 - 2.60
52wk Range:2.38 - 5.50
Volume:36,456
Avg Vol (3m):95,553
Market Cap:51.69M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNUp 1.97%51.69M
BSDMDown 1.52%18.76M
DCTHDown 0.57%16.44M
MMSIUp 15.61%643.66M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):101.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback